| General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs Y Ohno, A Hisaka, H Suzuki Clinical pharmacokinetics 46, 681-696, 2007 | 193 | 2007 |
| Prediction of pharmacokinetic drug–drug interaction caused by changes in cytochrome P450 activity using in vivo information A Hisaka, Y Ohno, T Yamamoto, H Suzuki Pharmacology & therapeutics 125 (2), 230-248, 2010 | 114 | 2010 |
| General Framework for the Prediction of Oral Drug Interactions Caused by CYP3A4 Induction from In Vivo Information Y Ohno, A Hisaka, M Ueno, H Suzuki Clinical pharmacokinetics 47, 669-680, 2008 | 110 | 2008 |
| A proposal for a pharmacokinetic interaction significance classification system (PISCS) based on predicted drug exposure changes and its potential application to alert … A Hisaka, M Kusama, Y Ohno, Y Sugiyama, H Suzuki Clinical pharmacokinetics 48, 653-666, 2009 | 49 | 2009 |
| Theoretical considerations on quantitative prediction of drug-drug interactions A Hisaka, Y Ohno, T Yamamoto, H Suzuki Drug metabolism and pharmacokinetics 25 (1), 48-61, 2010 | 31 | 2010 |
| Prediction and assessment of extrapyramidal side effects induced by risperidone based on dopamine D2 receptor occupancy Y Yamada, Y Ohno, Y Nakashima, M Fukuda, R Takayanagi, H Sato, ... Synapse 46 (1), 32-37, 2002 | 30 | 2002 |
| Pharmacokinetic and pharmacodynamic analysis of systemic effect of topically applied timolol maleate ophthalmic gelling vehicle (Rysmon® TG) Y Ohno, R Takayanagi, T Iga, Y Yamada, M Nagahara, M Araie Current eye research 30 (4), 319-328, 2005 | 23 | 2005 |
| Classification of drugs for evaluating drug interaction in drug development and clinical management K Maeda, A Hisaka, K Ito, Y Ohno, A Ishiguro, R Sato, N Nagai Drug metabolism and pharmacokinetics 41, 100414, 2021 | 19 | 2021 |
| The JAPAN-FORTA (Fit fOR The Aged) list: Consensus validation of a clinical tool to improve drug therapy in older adults F Pazan, Y Gercke, C Weiss, M Wehling, H Akazawa, T Kojima, R Kumaki, ... Archives of Gerontology and Geriatrics 91, 104217, 2020 | 14 | 2020 |
| Persistent drug interaction between aprepitant and warfarin in patients receiving anticancer chemotherapy Y Ohno, M Yamada, R Yamaguchi, A Hisaka, H Suzuki International journal of clinical pharmacy 36, 1134-1137, 2014 | 9 | 2014 |
| Prevalence of cytochrome P450‐mediated potential drug–drug interactions in residents of intermediate care facilities for older adults in Japan S Hamada, Y Ohno, T Kojima, S Ishii, J Okochi, M Akishita Geriatrics & Gerontology International 19 (6), 513-517, 2019 | 8 | 2019 |
| Assessment of drug–drug interaction between warfarin and aprepitant and its effects on PT-INR of patients receiving anticancer chemotherapy J Takaki, Y Ohno, M Yamada, R Yamaguchi, A Hisaka, H Suzuki Biological and Pharmaceutical Bulletin 39 (5), 863-868, 2016 | 7 | 2016 |
| Pharmacokinetic/pharmacodynamic analysis of neutrophil proliferation induced by rhG-CSF in patients receiving antineoplastic drugs M Sugiura, Y Ohno, Y Yamada, H Suzuki, T Iga Yakugaku Zasshi 124 (9), 599-604, 2004 | 7 | 2004 |
| Analysis of pharmacokinetic data provided in Japanese package inserts and interview forms focusing on urinary excretion of pharmacologically active species Y Ohno, M Kusama, A Hisaka, Y Yanagihara, H Suzuki Yakugaku zasshi 126 (7), 489-494, 2006 | 6 | 2006 |
| 病棟薬剤師の配置展開が処方提案および相談応需に与える効果 小久江伸介， 大野能之， 折山豊仁， 山口諒， 徳田篤志， 長瀬幸恵， ... 医療薬学 42 (10), 694-700, 2016 | 5 | 2016 |
| Dual EGFR and ABL tyrosine kinase inhibitor treatment in a patient with concomitant EGFR-mutated lung adenocarcinoma and BCR-ABL1-positive CML K Watanabe, H Kage, S Nagoshi, K Toyama, Y Ohno, A Shinozaki-Ushiku, ... Case Reports in Oncological Medicine 2020, 2020 | 3 | 2020 |
| CRRT 中の薬物投与量--抗菌薬の投与量設計を中心として 山本武人， 樋坂章博， 大野能之 Intensivist= インテンシヴィスト 2 (2), 329-345, 2010 | 3 | 2010 |
| 薬剤管理指導業務における副作用モニタリングの標準化と監査の試み 糖尿病代謝内科および腎臓内分泌内科病棟において 大野能之， 草間真紀子， 伊藤愛美， 高柳理早， 高山和郎， 青山隆夫， ... 医療薬学 30 (12), 794-803, 2004 | 3 | 2004 |
| Pharmacokinetic and pharmacodynamic analysis of the antihypercalcemic effect of incadronate disodium in rats Y Ohno, Y Yamada, T Usui, K Takahashi, F Tsuchiya, H Ohtani, H Sato, ... Biological and Pharmaceutical Bulletin 24 (11), 1290-1293, 2001 | 3 | 2001 |
| Quantitative Prediction of Drug-Drug Interaction Caused by CYP Inhibition and Induction from In Vivo Data and Its Application in Daily Clinical Practices-Proposal for the … Y Ohno Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 138 (3), 337-345, 2018 | 2 | 2018 |
